Literature DB >> 17938441

Bone marrow stem cells and liver disease.

Andre Castro Lyra, Milena Botelho Pereira Soares, Ricardo Ribeiro dos Santos, Luiz Guilherme Costa Lyra.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17938441      PMCID： PMC2095681     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

Authors:  Andre Castro Lyra; Milena Botelho Pereira Soares; Luiz Flavio Maia da Silva; Marcos Fraga Fortes; André Goyanna Pinheiro Silva; Augusto César de Andrade Mota; Sheilla A Oliveira; Eduardo Lorens Braga; Wilson Andrade de Carvalho; Bernd Genser; Ricardo Ribeiro dos Santos; Luiz Guilherme Costa Lyra
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

2.  Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.

Authors:  Shuji Terai; Tsuyoshi Ishikawa; Kaoru Omori; Koji Aoyama; Yoshio Marumoto; Yohei Urata; Yuichirou Yokoyama; Koichi Uchida; Takahiro Yamasaki; Yasuhiko Fujii; Kiwamu Okita; Isao Sakaida
Journal:  Stem Cells       Date:  2006-06-15       Impact factor: 6.277

3.  Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor.

Authors:  Myrtle Y Gordon; Natasa Levicar; Madhava Pai; Philippe Bachellier; Ioannis Dimarakis; Faisal Al-Allaf; Hanane M'Hamdi; Tamara Thalji; Jonathan P Welsh; Stephen B Marley; John Davies; Francesco Dazzi; Federica Marelli-Berg; Paul Tait; Raymond Playford; Long Jiao; Steen Jensen; Joanna P Nicholls; Ahmet Ayav; Mahrokh Nohandani; Farzin Farzaneh; Joop Gaken; Rikke Dodge; Malcolm Alison; Jane F Apperley; Robert Lechler; Nagy A Habib
Journal:  Stem Cells       Date:  2006-03-23       Impact factor: 6.277
  3 in total
  2 in total

Review 1.  Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.

Authors:  Shuji Terai; Haruko Tanimoto; Masaki Maeda; Junichi Zaitsu; Takuro Hisanaga; Takuya Iwamoto; Koichi Fujisawa; Yuko Mizunaga; Toshihiko Matsumoto; Yohei Urata; Yoshio Marumoto; Isao Hidaka; Tsuyoshi Ishikawa; Yuichiro Yokoyama; Koji Aoyama; Masako Tsuchiya; Taro Takami; Kaoru Omori; Naoki Yamamoto; Makoto Segawa; Koichi Uchida; Takahiro Yamasaki; Kiwamu Okita; Isao Sakaida
Journal:  J Gastroenterol       Date:  2012-04-05       Impact factor: 7.527

2.  Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice.

Authors:  Youkun Bi; Xuejun Guo; Mengqi Zhang; Keqi Zhu; Chentao Shi; Baoqi Fan; Yanyun Wu; Zhiguang Yang; Guangju Ji
Journal:  Stem Cell Res Ther       Date:  2021-12-11       Impact factor: 6.832
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.